<xml>
  <Module id='0'>
    <Heading>
      Introduction to Clinical Trials
    </Heading>
    <ResponseID>pra101</ResponseID>
    <ResponseID>pra102</ResponseID>
    <ResponseID>pra103</ResponseID>
    <ResponseID>pra104</ResponseID>
    <ResponseID>pra204</ResponseID>
  </Module>
  <Module id='1'>
    <Heading>
      Participating in a Clinical Trial
    </Heading>
    <ResponseID>pra124</ResponseID>
    <ResponseID>pra117</ResponseID>
    <ResponseID>pra207</ResponseID>
    <ResponseID>pra205</ResponseID>
  </Module>
  <Module id='2'>
    <Heading>
      Rheumatoid Arthritis (RA) and Inflammation
    </Heading>
    <ResponseID>prb208</ResponseID>
    <ResponseID>prb213</ResponseID>
    <ResponseID>prb215</ResponseID>
    <ResponseID>prb216</ResponseID>
  </Module>
  <Module id='3'>
    <Heading>
      RA Treatments and Biosimilars
    </Heading>
    <ResponseID>prb222</ResponseID>
    <ResponseID>prb224</ResponseID>
    <ResponseID>prb225</ResponseID>
    <ResponseID>prb190</ResponseID>
  </Module>
  <Module id='4'>
    <Heading>
      Reflections Study B538-02
    </Heading>
    <ResponseID>prc139</ResponseID>
    <ResponseID>prc159</ResponseID>
    <ResponseID>prc166</ResponseID>
    <ResponseID>prb231</ResponseID>
    <ResponseID>prc167</ResponseID>
  </Module>
  <Module id='5'>
    <Heading>
      Participant Information
    </Heading>
    <ResponseID>prb145</ResponseID>
    <ResponseID>prb148</ResponseID>
    <ResponseID>prb128</ResponseID>
    <ResponseID>prb239</ResponseID>
    <ResponseID>prb181</ResponseID>
  </Module>
</xml>
